SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: dshade, Dadx4
Search This Board:
Last Post: 12/2/2016 10:25:44 AM - Followers: 321 - Board type: Free - Posts Today: 0

     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.


ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact:
Media Contact:

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit

Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.


World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  


NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods. (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Organovo to Present at 28th Annual Piper Jaffray Healthcare Conference 11/22/2016 08:05:00 AM
ONVO News: Statement of Changes in Beneficial Ownership (4) 11/18/2016 05:11:40 PM
ONVO News: Statement of Changes in Beneficial Ownership (4) 11/18/2016 05:09:58 PM
ONVO News: Statement of Changes in Beneficial Ownership (4) 11/18/2016 05:09:00 PM
ONVO News: Statement of Changes in Beneficial Ownership (4) 11/18/2016 05:07:46 PM
#9671  Sticky Note Organovo Announces Fiscal Second-Quarter 2017 Results; Company Affirms Dadx4 11/03/16 04:25:02 PM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#9703   Top 10 Innovations 2016-ONVO is #2 12/1/16 trail_girl 12/02/16 10:25:44 AM
#9702   Evercore Partners initiates coverage for ORGANOVO HOLDINGS INC RandolRocketman 12/01/16 08:59:58 AM
#9701   Today: 3 Ways Organovo Holdings, Inc. Plans to rayank 12/01/16 08:15:34 AM
#9700   good luck tony. rayank 12/01/16 08:12:04 AM
#9699   Appreciate it. I hope it holds also. I'd tonyjh 12/01/16 08:06:54 AM
#9698   I see $3 as a support level tony rayank 12/01/16 07:57:54 AM
#9697   I hear you...been in this one awhile now, wiredawg 12/01/16 12:36:56 AM
#9696   Here is the Harvard Lab mentioned in the WHP03 11/30/16 09:17:07 PM
#9695   Looks like she is a professional marketer..... tonyjh 11/30/16 08:53:19 PM
#9694   Yes, that's the same web page. BuckeyeStocks 11/30/16 08:52:43 PM
#9693   Original Link to the article? WHP03 11/30/16 08:42:38 PM
#9692   There's no mention of Organovo in this article, BuckeyeStocks 11/30/16 06:30:28 PM
#9691   I sold today as well. Looking strictly at tonyjh 11/30/16 05:06:32 PM
#9690   Frustrated! I am a long-term believer in trail_girl 11/30/16 09:54:04 AM
#9689   Evercore ISI initiates coverage on Organovo Holdings (NASDAQ: WHP03 11/29/16 01:47:59 AM
#9688   Here's the article minus the About statement added BuckeyeStocks 11/22/16 08:37:45 AM
#9687   Organovo to Present at 28th Annual Piper Jaffray BuckeyeStocks 11/22/16 08:36:03 AM
#9686   Moving here from the other board since it cashmoo2 11/18/16 01:23:33 PM
#9685   Organovo (ONVO) presents at Canaccord Genuity Medical Technology BuckeyeStocks 11/18/16 12:35:56 PM
#9684   Technical Reports on Healthcare Equities -- Organovo, --- RandolRocketman 11/17/16 10:45:30 AM
#9683   Organovo to Present at 2016 Canaccord Genuity Medical BuckeyeStocks 11/14/16 08:42:15 AM
#9682   Brief, fleeting, generic mention of 3D bio-printing, but morley480 11/09/16 10:58:57 PM
#9681   PBS TV out of Buffalo tonight at 10pm morley480 11/09/16 09:13:17 PM
#9680   boncing nicely off that 6 mo double bottom dshade 11/09/16 01:09:31 PM
#9679   Nice to see ONVO moving higher this morning... WHP03 11/09/16 09:42:48 AM
#9678   Zacks Investment Research, Inc. upgrades ORGANOVO HOLDINGS INC RandolRocketman 11/09/16 09:29:50 AM
#9677   Thomson Reuters/Verus downgrades ORGANOVO HOLDINGS INC from BUY RandolRocketman 11/09/16 09:29:18 AM
#9676   Yes - Growth stocks will become Income stocks BuckeyeStocks 11/04/16 10:48:58 AM
#9675   Agreed. I also liked the statement where Windbag1014 11/04/16 10:43:43 AM
#9674   I found this statement from Murphy to be BuckeyeStocks 11/04/16 10:32:58 AM
#9673   Not too shabby. Better than I was Windbag1014 11/04/16 10:09:47 AM
#9672   Organovo Holdings' (ONVO) CEO Keith Murphy on Q2 BuckeyeStocks 11/03/16 09:45:13 PM
#9671   Organovo Announces Fiscal Second-Quarter 2017 Results; Company Affirms Dadx4 11/03/16 04:25:02 PM
#9670   ONVO 10Q; Dadx4 11/03/16 04:19:04 PM
#9669   I thought that the first clinical study was RandolRocketman 11/03/16 08:51:19 AM
#9668   Market Capitalization $261.59M RandolRocketman 11/02/16 11:06:41 PM
#9667   Keith needed more steak dinners. That's what the RallyTheMarket 11/02/16 04:34:33 PM
#9666   How did they convince investors to dump 20 thewind 11/02/16 03:36:01 PM
#9665   you'll know when you feel it...!! bigideaportugal 11/02/16 01:13:48 PM
#9664 stick - which way? nsomniyak 11/01/16 10:25:05 PM
#9663   Hockey stick is coming!!! Don't know when,, but bigideaportugal 11/01/16 07:09:16 PM
#9662   Something is afoot? At first, I was highly bettyfordallstar 11/01/16 06:36:52 PM
#9661   seems like covering before earnings thewind 11/01/16 04:36:52 PM
#9660   Is this news going to drive this higher Marketwise 11/01/16 03:37:29 PM
#9659   Shorts covering...weekly shows it's not in free fall...yet...depends thewind 11/01/16 12:59:51 PM
#9658   ONVO---GLTA! Dadx4 11/01/16 11:28:27 AM
#9657   Snapshot:ONVO ORGANOVO HOLDINGS INC RandolRocketman 11/01/16 10:57:43 AM
#9656   Show me the money. RallyTheMarket 11/01/16 09:58:33 AM
#9655   SAN DIEGO, Nov. 01, 2016 (GLOBE NEWSWIRE) -- RandolRocketman 11/01/16 08:14:17 AM
#9654   3 Things to Watch in Organovo Holdings, Inc. rayank 11/01/16 08:02:57 AM